1. Introduction
irreparable loss of connective tissue, impaired dentition, bone gain, periodontitis, intrabony defects, bone defects
PERIODONTITIS, PERIODONTAL DISEASE, GROUP B, PERIODONTITIS
(1) Background: Guided tissue regeneration was an effective surgical procedure in the management of intrabony defects and has undergone a number of changes in terms of materials and techniques. The aim of this study is to compare AmnioGuard and BioMesh in combination with NovaBone putty in intrabony defects. (2) Methodology: Ten patients who needed regenerative periodontal therapy were randomly allocated into two groups based on the inclusion criteria. These patients were subjected to phase I therapy followed by which Group A patients were treated with AmnioGuard + NovaBone putty whereas Group B with BioMesh + NovaBone putty. The clinical indices were obtained at baseline, 3 months and 6 months post-operatively while radiographic parameters were obtained at 6 months post-op. (3) Results & Conclusion: At six months after surgery, Group B (33% bone gain) showed a statistically significant change from Group A (16% bone gain) in both the clinical and radiographic measures (Periodontitis is a periodontal disease that causes irreparable loss of connective tissue attachment and supporting alveolar bone. These modifications frequently result in aesthetically and functionally impaired dentition. Periodontists have been interested in rebuilding tissues lost by periodontitis in bone defects for many decades. Periodontal regeneration is the complete return of the missing tissues to their original form and function by reenacting the key wound-healing processes that were involved in their formation.Isolation for selective cell repopulation has been a recognized therapeutic approach for treating periodontal intrabony abnormalities for almost 30 years. Melcher [In recent years, biological barrier membranes have gained importance in periodontal regeneration. Amniotic membrane (AmnioGuard